TipRanks
Advertisement
Advertisement

LGND Stock Latest News

Twilio downgraded, Synopsys upgraded: Wall Street’s top analyst calls
The FlyTwilio downgraded, Synopsys upgraded: Wall Street’s top analyst calls
10d ago
CF
AGO
Ligand initiated with an Overweight at Barclays
PremiumThe Fly
Ligand initiated with an Overweight at Barclays
10d ago
LGND
Wainwright sees upside in Ligand after new CAR-T investment in AvenCell
PremiumThe Fly
Wainwright sees upside in Ligand after new CAR-T investment in AvenCell
11d ago
LGND
Ligand Pharma Announces $47 Million AvenCell Financing Deal
PremiumCompany Announcements
Ligand Pharma Announces $47 Million AvenCell Financing Deal
11d ago
8K
LGND
Ligand enters financing agreement with AvenCell for up to $47M
PremiumThe Fly
Ligand enters financing agreement with AvenCell for up to $47M
11d ago
LGND
Ligand price target raised to $397 from $390 at Citi
PremiumThe FlyLigand price target raised to $397 from $390 at Citi
12d ago
LGND
Analyst Reiterates Buy on Ligand as Ryjunea Royalty Deal Highlights Disciplined Capital Deployment and Supports Unchanged $388 Price Target
Premium
Ratings
Analyst Reiterates Buy on Ligand as Ryjunea Royalty Deal Highlights Disciplined Capital Deployment and Supports Unchanged $388 Price Target
12d ago
LGND
Ligand enters royalty agreement with Sydnexis for Ryjunea
Premium
The Fly
Ligand enters royalty agreement with Sydnexis for Ryjunea
13d ago
LGND
Ligand Pharma Expands Ophthalmology Royalties With Ryjunea Deal
PremiumCompany Announcements
Ligand Pharma Expands Ophthalmology Royalties With Ryjunea Deal
13d ago
8K
LGND
Ligand acquires royalty, milestone interest in Santen’s Ryjunea from Sydnexis
PremiumThe Fly
Ligand acquires royalty, milestone interest in Santen’s Ryjunea from Sydnexis
13d ago
LGND
Ligand Pharmaceuticals Earnings Call Signals Royalty-Driven Surge
PremiumCompany Announcements
Ligand Pharmaceuticals Earnings Call Signals Royalty-Driven Surge
2M ago
LGND
Ligand price target raised to $390 from $387 at Citi
PremiumThe Fly
Ligand price target raised to $390 from $387 at Citi
2M ago
LGND
Ligand initiated with an Outperform at Leerink
PremiumThe FlyLigand initiated with an Outperform at Leerink
2M ago
LGND
Ligand price target raised to $345 from $340 at RBC Capital
Premium
The Fly
Ligand price target raised to $345 from $340 at RBC Capital
2M ago
LGND
Ligand price target raised to $358 from $289 at H.C. Wainwright
Premium
The Fly
Ligand price target raised to $358 from $289 at H.C. Wainwright
2M ago
LGND
Ligand reports Q2 adjusted EPS $2.37, consensus $1.97
PremiumThe Fly
Ligand reports Q2 adjusted EPS $2.37, consensus $1.97
2M ago
LGND
Ligand narrows FY26 adjusted EPS view to $9.00-$9.50 from $8.50-$9.50
PremiumThe Fly
Ligand narrows FY26 adjusted EPS view to $9.00-$9.50 from $8.50-$9.50
2M ago
LGND
LGND Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LGND Upcoming Earnings Report: What to Expect?
2M ago
LGND
Ligand price target raised to $326 from $285 at Oppenheimer
PremiumThe Fly
Ligand price target raised to $326 from $285 at Oppenheimer
2M ago
LGND
Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
PremiumThe FlyShopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
3M ago
GS
RL
Ligand resumed with a Buy at Citi
Premium
The Fly
Ligand resumed with a Buy at Citi
3M ago
LGND
Ligand price target raised to $345 from $330 at Craig-Hallum
Premium
The Fly
Ligand price target raised to $345 from $330 at Craig-Hallum
3M ago
SNY
LGND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >